• All
  • Important
  • Financial Update
  • Fund Raise
  • Board Meeting
  • Dividend/Bonus
  • JV/Acquisition
  • Investor Meet
  • Insider Trade
  • Pledging
  • Others
    ALPHA TRIBE

    Nectar Lifesciences Limited — Board Meeting, 14-08-2026: Outcome of Board Meeting

    14-08-2026 | 09:04 pm

    Nectar Lifesciences' board approved Q1 consolidated results, reporting a ₹15.40 Cr loss due to investment volatility. Dr. Gunmala Suri was appointed as an Additional Director. The 31st AGM is scheduled for Sept 18 as the company re-focuses on real estate ventures.

    No comments yet. Be the first to comment!

    All announcements from Nectar Lifesciences Limited